BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 28789478)

  • 1. Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.
    Mishima T; Koga S; Lin WL; Kasanuki K; Castanedes-Casey M; Wszolek ZK; Oh SJ; Tsuboi Y; Dickson DW
    J Neuropathol Exp Neurol; 2017 Aug; 76(8):676-682. PubMed ID: 28789478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the genetics and pathology of Perry syndrome.
    Wider C; Dachsel JC; Farrer MJ; Dickson DW; Tsuboi Y; Wszolek ZK
    J Neurol Sci; 2010 Feb; 289(1-2):149-54. PubMed ID: 19732908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pallidonigral TDP-43 pathology in Perry syndrome.
    Wider C; Dickson DW; Stoessl AJ; Tsuboi Y; Chapon F; Gutmann L; Lechevalier B; Calne DB; Personett DA; Hulihan M; Kachergus J; Rademakers R; Baker MC; Grantier LL; Sujith OK; Brown L; Calne S; Farrer MJ; Wszolek ZK
    Parkinsonism Relat Disord; 2009 May; 15(4):281-6. PubMed ID: 18723384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral defects in a DCTN1
    Mishima T; Deshimaru M; Watanabe T; Kubota K; Kinoshita-Kawada M; Yuasa-Kawada J; Takasaki K; Uehara Y; Jinno S; Iwasaki K; Tsuboi Y
    Neurosci Lett; 2018 Feb; 666():98-103. PubMed ID: 29273399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCTN1-related neurodegeneration: Perry syndrome and beyond.
    Konno T; Ross OA; Teive HAG; Sławek J; Dickson DW; Wszolek ZK
    Parkinsonism Relat Disord; 2017 Aug; 41():14-24. PubMed ID: 28625595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
    Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing diagnostic criteria for Perry syndrome.
    Mishima T; Fujioka S; Tomiyama H; Yabe I; Kurisaki R; Fujii N; Neshige R; Ross OA; Farrer MJ; Dickson DW; Wszolek ZK; Hattori N; Tsuboi Y
    J Neurol Neurosurg Psychiatry; 2018 May; 89(5):482-487. PubMed ID: 29089398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCTN1 mutations in Perry syndrome.
    Farrer MJ; Hulihan MM; Kachergus JM; Dächsel JC; Stoessl AJ; Grantier LL; Calne S; Calne DB; Lechevalier B; Chapon F; Tsuboi Y; Yamada T; Gutmann L; Elibol B; Bhatia KP; Wider C; Vilariño-Güell C; Ross OA; Brown LA; Castanedes-Casey M; Dickson DW; Wszolek ZK
    Nat Genet; 2009 Feb; 41(2):163-5. PubMed ID: 19136952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and pathological spectrum of TDP-43 associated ALS].
    Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
    Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCTN1 F52L mutation case of Perry syndrome with progressive supranuclear palsy-like tauopathy.
    Honda H; Sasagasako N; Shen C; Shijo M; Hamasaki H; Suzuki SO; Tsuboi Y; Fujii N; Iwaki T
    Parkinsonism Relat Disord; 2018 Jun; 51():105-110. PubMed ID: 29499916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perry syndrome: a case of atypical parkinsonism with confirmed DCTN1 mutation.
    McManus EJ; Poke G; Phillips MC; Asztely F
    N Z Med J; 2020 Apr; 133(1513):116-118. PubMed ID: 32325477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome.
    Čierny M; Hooshmand SI; Fee D; Tripathi S; Dsouza NR; La Pean Kirschner A; Zimmermann MT; Brennan R
    Parkinsonism Relat Disord; 2020 Aug; 77():110-113. PubMed ID: 32712562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation.
    Deshimaru M; Kinoshita-Kawada M; Kubota K; Watanabe T; Tanaka Y; Hirano S; Ishidate F; Hiramoto M; Ishikawa M; Uehara Y; Okano H; Hirose S; Fujioka S; Iwasaki K; Yuasa-Kawada J; Mishima T; Tsuboi Y
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FTLD/ALS as TDP-43 proteinopathies].
    Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
    Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
    King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
    Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.
    Armstrong RA; Ellis W; Hamilton RL; Mackenzie IR; Hedreen J; Gearing M; Montine T; Vonsattel JP; Head E; Lieberman AP; Cairns NJ
    J Neural Transm (Vienna); 2010 Feb; 117(2):227-39. PubMed ID: 20012109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy.
    Thorpe JR; Tang H; Atherton J; Cairns NJ
    J Neural Transm (Vienna); 2008 Dec; 115(12):1661-71. PubMed ID: 18974920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.